Researchers Design COVID-19 Knowledge Base and Risk Assessment Tool Powered by Artificial Intelligence

FAU’s College of Engineering and Computer Science Machine Learning Project Receives NSF RAPID Grant
24-Jun-2020 8:30 AM EDT, by Florida Atlantic University

Newswise — Researchers from Florida Atlantic University’s College of Engineering and Computer Science, in collaboration with FAU’s Schmidt College of Medicine, have received a one-year, $90,000 National Science Foundation (NSF) RAPID project grant to conduct research using social networks and machine learning, facilitated by molecular genetics and viral infection, for COVID-19 modeling and risk evaluation. The project will create a web-based COVID-19 knowledge base, as well as a risk evaluation tool for individuals to assess their infection risk in a dynamic environment.

“COVID-19 is an evolving epidemic and there is little knowledge about its outbreak and spread patterns, or the impact of viral evolution, demography, social behavior, cultural differences, and quarantine policies regarding these outbreaks,” said Stella Batalama, Ph.D., dean of FAU’s College of Engineering and Computer Science. “As the battle against COVID-19 continues, a deluge of information is being produced. As a result, the dramatic outbreak differences with respect to diverse geographies, regional policies, and cultural groups is raising confusion, contradictions, and inconsistencies in disease outbreak modeling.”

The FAU project, “RAPID: COVID-19 Coronavirus Testbed and Knowledge Base Construction and Personalized Risk Evaluation,” will address these discrepancies by building a knowledge base of COVID-19 to understand the correlations and roles that different factors play in predicting the spread of the virus. The technology will result in the implementation of appropriate policies to mitigate the effects of the epidemic on public health and society-at-large.  

“Academia, news agencies, and governments are continuously publishing advances in the understanding of the virus’ clinical pathologies, its genome sequences, and relevant administrative policies and actions taken. In addition, the public also responds to the changing environments through social media sites or other online sources, resulting in real-time social sensing opportunities,” said Xingquan (Hill) Zhu, Ph.D., principal investigator (PI) of the grant and a professor in FAU’s Department of Computer and Electrical Engineering and Computer Science. “This is why a knowledge base of COVID-19 using machine learning is so crucial for us to model and understand the spread of COVID-19, and eventually mitigate the negative effects of the virus on public health, society, and the economy.”

The technical aims of the FAU project are two-fold. First, researchers will create a knowledge base that includes information for modeling outbreak and mutation of COVID-19, which will serve as a benchmark for better understanding the spread of the virus. The second aim of the project is to develop a multi-source deep neural network-based predictive tool to combine demographics, policies, regional infections, and individual information for risk evaluation.

“The COVID-19 knowledge base uses graph/network to represent entities and their relationships. The entities are fully compatible to the Unified Medical Language System or UMLS standard for convenient knowledge sharing. Supported by the knowledge base, the public will be able to employ information to estimate their infection risk level using social and behavioral information such as their family size, shopping patterns, and dining patterns, as well as local authority policies such as school, restaurant, and movie theater closures and night time curfews,” said Zhu. “They also will have access to demographic information such as population age, density and income, as well as health conditions like heart disease incidence, cancer prevalence, and substance misuse. Public health officials and the public-at-large also will be able to access regional virus conditions such as the number of infection cases in the area studied and infection rate.”

Co-investigators of the FAU NSF RAPID grant are Michael DeGiorgio, Ph.D., an assistant professor in the Department of Computer and Electrical Engineering and Computer Science; and Massimo Caputi, Ph.D., a professor of biomedical science in FAU’s Schmidt College of Medicine. Caputi has developed novel techniques to study RNA – RNA binding protein interactions, and has made important contributions in the understanding of how cellular proteins modulate the replication of the HIV-1 genome. He has expanded his research through collaborative grants for the development of microfluidic diagnostic devices to detect multiple viral species from blood and other bodily fluids.

Since receiving the NSF grant in May, the research team has made significant progress. The team, which includes three Ph.D. students – Zhabiz Gharibshah, Magdalyn E. Elkin, and Anak Wannaphaschaiyong – has already implemented knowledge base dashboard and infection, and social sensing dashboard, and is currently working on the risk estimation dashboard.  

Filters close

Showing results

110 of 3446
Released: 29-Sep-2020 7:05 PM EDT
Research into SARS-CoV-2 mutation “hotspots” raises implications for vaccines and therapeutics
UCLA Fielding School of Public Health

Researchers have found at least 10 distinct “hotspot” mutations in more than 80% of randomly selected SAR-CoV-2 sequences from six countries, and these genome hotspots – seen as "typos" that can occur as the virus replicates during cellular division – could have a significant impact in the fight against the COVID-19 pandemic.

Newswise: New “Buzz” about Fighting COVID-19 at Baltimore-Area Barbershops
Released: 29-Sep-2020 6:30 PM EDT
New “Buzz” about Fighting COVID-19 at Baltimore-Area Barbershops
LifeBridge Health

LifeBridge Health Partners with Live Chair Health to Offer Coronavirus Support And Expansion of Barbershop Health Screening Program

access_time Embargo lifts in 2 days
Embargo will expire: 30-Sep-2020 7:05 PM EDT Released to reporters: 29-Sep-2020 5:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Sep-2020 7:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Eccles School Launches Postdoctoral Program in Entrepreneurship & Strategy
Released: 29-Sep-2020 4:45 PM EDT
Eccles School Launches Postdoctoral Program in Entrepreneurship & Strategy
University of Utah, David Eccles School of Business

The Department of Entrepreneurship & Strategy at the University of Utah’s David Eccles School of Business launched a new postdoctoral fellowship program with the hire of Maria Kurakina, a young scholar with a Ph.D. from the University of California at Berkeley, Haas School of Business.

Released: 29-Sep-2020 4:35 PM EDT
Study supports airborne spread of COVID-19 indoors
University of Georgia

New research from the University of Georgia supports growing evidence for airborne transmission of COVID-19 in enclosed spaces.

Newswise: 244300_web.jpg
Released: 29-Sep-2020 3:35 PM EDT
Conversation quickly spreads droplets inside buildings
Princeton University School of Engineering and Applied Science

With implications for the transmission of diseases like COVID-19, researchers have found that ordinary conversation creates a conical 'jet-like' airflow that quickly carries a spray of tiny droplets from a speaker's mouth across meters of an interior space.

Released: 29-Sep-2020 2:25 PM EDT
VirScan offers new insights into COVID-19 antibody response
Brigham and Women’s Hospital

A tool designed to detect viral history in a drop of blood has gotten an upgrade in the age of COVID-19.

Newswise: 244362_web.jpg
Released: 29-Sep-2020 1:50 PM EDT
In a field where smaller is better, researchers discover the world's tiniest antibodies
University of Bath

Researchers at the University of Bath in the UK and biopharma company UCB have found a way to produce miniaturised antibodies, opening the way for a potential new class of treatments for diseases.

Showing results

110 of 3446